TY - GEN
T1 - Estimation of Yttrium-90 Distribution in Liver Radioembolization using Computational Fluid Dynamics and Deep Neural Networks
AU - Taebi, Amirtaha
AU - Vu, Catherine T.
AU - Roncali, Emilie
PY - 2020/7
Y1 - 2020/7
N2 - Yttrium-90 (90Y) radioembolization is a liver cancer therapy based on 90Y microspheres injected into the hepatic artery. Current dosimetry methods used to estimate the absorbed dose in order to prescribe the 90Y activity to inject are not accurate, which can affect the treatment effectiveness. A new dosimetry based on the hemodynamics simulation of the hepatic arterial tree, CFDose, aimed at overcoming some of the limitations of the current methods. However, due to the expensive computational cost of computational fluid dynamics (CFD) simulations, this method needs to be accelerated before it can be used in real-time during treatment planning. In this paper, we introduce a convolutional neural network model trained with the CFD results of a patient with hepatocellular carcinoma to predict the 90Y distribution under different downstream vasculature resistance conditions. The model performance was evaluated using two metrics, the mean squared error and prediction accuracy. The prediction accuracy showed that the average difference between the actual and predicted data was less than 1%. The proposed model could estimate the 90Y distribution significantly faster than a CFD simulation.
AB - Yttrium-90 (90Y) radioembolization is a liver cancer therapy based on 90Y microspheres injected into the hepatic artery. Current dosimetry methods used to estimate the absorbed dose in order to prescribe the 90Y activity to inject are not accurate, which can affect the treatment effectiveness. A new dosimetry based on the hemodynamics simulation of the hepatic arterial tree, CFDose, aimed at overcoming some of the limitations of the current methods. However, due to the expensive computational cost of computational fluid dynamics (CFD) simulations, this method needs to be accelerated before it can be used in real-time during treatment planning. In this paper, we introduce a convolutional neural network model trained with the CFD results of a patient with hepatocellular carcinoma to predict the 90Y distribution under different downstream vasculature resistance conditions. The model performance was evaluated using two metrics, the mean squared error and prediction accuracy. The prediction accuracy showed that the average difference between the actual and predicted data was less than 1%. The proposed model could estimate the 90Y distribution significantly faster than a CFD simulation.
UR - http://www.scopus.com/inward/record.url?scp=85091003463&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091003463&partnerID=8YFLogxK
U2 - 10.1109/EMBC44109.2020.9176328
DO - 10.1109/EMBC44109.2020.9176328
M3 - Conference contribution
AN - SCOPUS:85091003463
T3 - Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS
SP - 4974
EP - 4977
BT - 42nd Annual International Conferences of the IEEE Engineering in Medicine and Biology Society
PB - Institute of Electrical and Electronics Engineers Inc.
T2 - 42nd Annual International Conferences of the IEEE Engineering in Medicine and Biology Society, EMBC 2020
Y2 - 20 July 2020 through 24 July 2020
ER -